US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

PAVM

PAVmed (PAVM)

PAVmed Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PAVM

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/06/2024	06:58	PR Newswire (US)	PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute	NASDAQ:PAVM	PAVmed Inc
12/06/2024	07:05	PR Newswire (US)	4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing	NASDAQ:PAVM	PAVmed Inc
13/05/2024	19:43	PR Newswire (US)	PAVmed Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
13/05/2024	07:00	PR Newswire (US)	Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results	NASDAQ:PAVM	PAVmed Inc
09/05/2024	06:49	PR Newswire (US)	Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall	NASDAQ:PAVM	PAVmed Inc
07/05/2024	06:39	PR Newswire (US)	Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors	NASDAQ:PAVM	PAVmed Inc
03/05/2024	07:35	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024	NASDAQ:PAVM	PAVmed Inc
02/05/2024	07:35	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024	NASDAQ:PAVM	PAVmed Inc
02/05/2024	06:49	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing	NASDAQ:PAVM	PAVmed Inc
30/04/2024	06:35	PR Newswire (US)	PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute	NASDAQ:PAVM	PAVmed Inc
29/04/2024	07:47	PR Newswire (US)	Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month	NASDAQ:PAVM	PAVmed Inc
08/04/2024	07:30	PR Newswire (US)	Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:PAVM	PAVmed Inc
26/03/2024	18:32	PR Newswire (US)	PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PAVM	PAVmed Inc
21/03/2024	08:30	PR Newswire (US)	Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population	NASDAQ:PAVM	PAVmed Inc
21/03/2024	07:30	PR Newswire (US)	PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX	NASDAQ:PAVM	PAVmed Inc
20/03/2024	07:30	PR Newswire (US)	Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference	NASDAQ:PAVM	PAVmed Inc
13/03/2024	07:30	PR Newswire (US)	PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024	NASDAQ:PAVM	PAVmed Inc
12/03/2024	07:30	PR Newswire (US)	Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024	NASDAQ:PAVM	PAVmed Inc
08/03/2024	15:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PAVM	PAVmed Inc
23/02/2024	15:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PAVM	PAVmed Inc
20/02/2024	15:45	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PAVM	PAVmed Inc
16/02/2024	16:00	PR Newswire (US)	Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	NASDAQ:PAVM	PAVmed Inc
15/02/2024	06:45	PR Newswire (US)	Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony	NASDAQ:PAVM	PAVmed Inc
14/02/2024	14:38	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PAVM	PAVmed Inc
08/02/2024	06:45	PR Newswire (US)	Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	NASDAQ:PAVM	PAVmed Inc
06/02/2024	16:17	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PAVM	PAVmed Inc
12/12/2023	07:30	PR Newswire (US)	Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	NASDAQ:PAVM	PAVmed Inc
11/12/2023	08:00	PR Newswire (US)	PAVmed Provides Additional Details for Upcoming Stock Dividend to Shareholders	NASDAQ:PAVM	PAVmed Inc
04/12/2023	15:20	PR Newswire (US)	PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock Split	NASDAQ:PAVM	PAVmed Inc
16/11/2023	08:00	PR Newswire (US)	Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting Efforts	NASDAQ:PAVM	PAVmed Inc

Showing the most relevant articles for your search:NASDAQ:PAVM

1 2 3 4 5 6 7 8 9 10 Próxima >

Invesco QQQ Trust Series 1

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones